Somatostatin analog (octreotide) and sirolimus immunosuppressive therapy in the treatment of chyloperitoneum and chylothorax in newborns and infants

• Main Authors: Aleksandra Gurskaya (Author), Mariya Sulavko (Author), Ekaterina Ekimovskaya (Author), Rimir Bayazitov (Author), Oleg Nakovkin (Author), Inna Karnuta (Author), Anna Klepikova (Author), Dinara Akhmedova (Author), Ruslan Hagurov (Author), Garik Sagoyan (Author), Yelena Dyakonova (Author), Andrey Fisenko (Author)
• Format: Book
• Published: EL-Med-Pub, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Chyloperitoneum (CP) and chylothorax (CT) are rare conditions that have a high mortality rate and unclear treatment options. Their incidence in neonates ranges from 1 in 20000 to 1 in 187000 live births. This study aims to evaluate the effectiveness of synthetic somatostatin analog (octr...